CNBC's Jim Cramer on Wednesday gave his call on two stocks: GW Pharmaceuticals and ConAgra Foods.
To start, Cramer flagged drug-maker GW Pharmaceuticals, which saw shares spike after it recently announced plans to sell 1.7 million shares in a secondary offering. He thinks investors should take advantage of the secondary, and buy the stock.
"This is the only really legitimate marijuana stock out there. It's a British company. It's doing very well," Cramer said on "Squawk on the Street."
The biopharmaceutical company grows cannabis under license at a secret location in Britain to make an array of experimental cannabis drugs.